Altimmune (ALT) stock dips as higher-than-expected R&D costs lead to a Q4 2025 earnings miss for the company. Read more here.
Conference Call Participants. Lee Roth - Burns McClellan, Inc. Jiale Song - Jefferies LLC, Research Division Jasmine Fels - Barclays Bank PLC, Research Division Dominic Lorenzi - ...
Altimmune, Inc. (NASDAQ:ALT) Q4 2025 Earnings Call Transcript March 5, 2026 Altimmune, Inc. misses on earnings expectations. Reported EPS is $-0.27191 EPS, expectations were $-0.25. Operator: Good ...
Feelies guitarist Glenn Mercer says the pressure was on to come up with a killer sophomore album – but having a little help ...
AtoZ Sports on MSN
2-Round 2026 NFL Mock Draft: Raiders reap rewards of the Maxx Crosby trade while Bears, Chiefs replace veterans dealt this week
The 2026 NFL Draft buzz is about to kick into overdrive. Free agency opens next week, which is going to dramatically shift ...
If you have the means to help, we’ve compiled verified pages linked to families that have setup GoFundMe sites to help with ...
You can buy it now at Amazon for $49, which is a savings of $21 or 30% off the normal $70.
Neudata, the authoritative source for global data intelligence, today published its annual report, "The state of the ...
Our friends at ALT 98.7 have an amazing event coming up – it’s the Woody Show After-Hours Takeover private party, happening at Disney California Adventure® Park on April 20th. Of ...
The Chargers sign center Tyler Biadasz to a $30M deal and are reportedly "keeping tabs" on an AJ Brown trade. See how Joe ...
PCMag on MSN
MSI MPG 271QR QD-OLED X50
None ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results